“Implications of Programmed Death Ligand-1 Positivity in Non-Clear Cell Renal Cell Carcinoma”, jkcvhl, vol. 5, no. 4, pp. 6–13, Oct. 2018, doi: 10.15586/jkcvhl.2018.107.